Cyclerion therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Cyclerion therapeutics Contact Number

Cyclerion Therapeutics 245 First Street Riverview II, 18th Floor Cambridge, MA 02142. Phone: 857-327-8778 Email: [email protected]cyclerion.com Fax: 617-890-6595

Contact US: https://www.cyclerion.com/contact/

Where is cyclerion therapeutics located in cambridge ma?

Cyclerion Therapeutics 245 First Street Riverview II, 18th Floor Cambridge, MA 02142 Phone: 857-327-8778 Email: [email protected] Fax: 617-890-6595 Investor Relations or Media Inquiries: [email protected] Partnering Inquiries: [email protected] Sponsorship Inquiries: [email protected] © 2021 Cyclerion Therapeutics, Inc.

What is cyclin therapeutics?

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion is advancing its portfolio of differentiated sGC stimulator programs with distinct pharmacologic and biodistribution properties ...

What is cycleragen therapeutics?

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.

What is cycle therapy?

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases.

CY6463

28 People Used

See More ››

Cyclerion

CY6463 is the revised compound name for IW-6463. IW-6463 will be referenced in various existing articles, trial descriptions, etc.

View Contact ››

Cyclerion

123 People Used

See More ››

Cyclerion Therapeutics, Inc. Company Profile Cambridge

Cyclerion Therapeutics, Inc. is located in Cambridge, MA, United States and is part of the Pharmaceutical Manufacturing Industry. Cyclerion Therapeutics, Inc. has 143 total employees across all of its locations and generates $2.30 million in sales (USD). There are 2 companies in the Cyclerion Therapeutics, Inc. corporate family.

View Contact ››

Tickets

82 People Used

See More ››

Cyclerion Therapeutics, Inc 245 1st St Cambridge, MA

Get directions, reviews and information for Cyclerion Therapeutics, Inc in Cambridge, MA. Cyclerion Therapeutics, Inc 245 1st St Cambridge MA 02142. Reviews (857) 327-8778 Website. Menu & Reservations Make Reservations . Order Online Tickets Tickets See Availability

View Contact ››

Functional

47 People Used

See More ››

Leadership Team • Cyclerion

Our Vice President of Corporate Development, Todd Milne, PhD, brings more than 20 years of experience in the biopharma industry. Prior to Cyclerion, Dr. Milne was a co-founder of Ironwood Pharmaceuticals where he held a number of scientific program and functional leadership roles, including leading sGC stimulator discovery and early development efforts at Ironwood.

View Contact ››

Cyclerion

69 People Used

See More ››

Cyclerion Therapeutics

Cyclerion Therapeutics Announces Departure of Chief Medical Officer CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced that Christopher Wright, M.D., Ph.D., Chief Medical Officer, has resigned his position with …

View Contact ››

History

53 People Used

See More ››

Peter Hecht

View Peter Hecht''s business profile as Chief Executive Officer at Cyclerion Therapeutics. Find contact''s direct phone number, email address, work history, and more.

View Contact ››

Business

53 People Used

See More ››

Cyclerion Therapeutics, Inc. (CYCN) Company Profile

See the company profile for Cyclerion Therapeutics, Inc. (CYCN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key …

View Contact ››

Cyclerion

75 People Used

See More ››

Cyclerion Therapeutics

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company. Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments …

View Contact ››

Annual

49 People Used

See More ››

SEC Filing Cyclerion Therapeutics, Inc.

Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. You are cordially invited to attend the annual meeting of stockholders of Cyclerion Therapeutics, Inc. The annual meeting will be held on June 24, 2021 at 8:00 a.m., Eastern Time. which shall include contact information for

View Contact ››

Please leave your comments here:

Popular Brands

Cnooc
Cae
Cerner
Csi
Cibc